Five carmakers in South Korea are voluntarily recalling a combined 210,738 vehicles of 76 models to fix faulty components, the Ministry of Land, Infrastructure, and Transport said.
GM Korea Co., BMW Group Korea, Audi-Volkswagen Korea, Nissan Motor Co., and Fiat Chrysler Automobiles NV (FCA) Korea has begun to provide or offer repair and replacement services.
Vehicle owners can contact repair and service centers to get free parts replacements. e
GM's Chevrolet Lacetti was found to have a faulty control unit for automatic transmission, while there was a flawed timing chain in BMW's 44 models and a faulty camshaft control system of Audi's A6 series vehicles.
It is the second recall effort by GM Korea in a month.
In November, the ministry announced that GM Korea, with Hyundai Motor, Kia Motors, Renault Samsung Motors, Mercedes-Benz Korea, and Daejun Machinery will recall a combined 163,843 cars in 19 models.


Johnson & Johnson Proposes $5.5 Billion Talc Settlement to Resolve U.S. Ovarian Cancer Lawsuits
Seagate Stock Jumps as AI-Fueled Earnings Beat and Strong FY2027 Outlook Impress Investors
TSMC Gradually Restarts Japan Chip Plant After Kumamoto Earthquake
Zabka Shares Drop 10% as Seven & i Abandons Investment Plans
Stellantis Sells Free2move Car-Sharing Business to Mutares to Strengthen Core Auto Strategy
Exosens H1 Profit Beats Forecasts as Defense Demand Drives Growth
Galp Shares Fall After Q2 EBITDA Miss Despite Profit Beat and Higher Dividend
Air Liquide Q2 Sales Growth Tops Forecast as Electronics Business Drives Strong Performance
TeamViewer Shares Fall Despite Profit Growth as ARR and Customer Base Decline
BHP, Port Hedland Unions Fail to Reach Wage Deal as Negotiations Continue
ASML, Applied Materials Slide as China DUV Chip Equipment Breakthrough Sparks Market Jitters
Meta CEO Zuckerberg Opposes U.S. Ban on Chinese AI Models, Warns Against Overregulation
Tech Stock Positioning Nears Neutral as Investor Rotation Enters Final Phase, Deutsche Bank Says
CXMT IPO Debut in Shanghai Puts $85.5 Billion Chipmaker in Spotlight
Brown-Forman Rejects Sazerac’s $15 Billion Takeover Bid as Family Backs Independence
Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9%
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 



